BXP
49
2
MHK
46
3
OI
34
6
BRK.B
27
2
BWA
44
3
ROST
57
3
EXPD
40
3
VMC
62
5
BEN
34
6
SYF
83
4
PHM
60
6
TDC
47
-39
PFE
21
-2
RSG
62
2
MSFT
46
2
AES
44
3
COF
60
3
HIG
54
2
PX
66
4
NOC
45
13
BXP
49
2
MHK
46
3
OI
34
6
BRK.B
27
2
BWA
44
3
ROST
57
3
EXPD
40
3
VMC
62
5
BEN
34
6
SYF
83
4
PHM
60
6
TDC
47
-39
PFE
21
-2
RSG
62
2
MSFT
46
2
AES
44
3
COF
60
3
HIG
54
2
PX
66
4
NOC
45
13
Financhill
Back

Treace Medical Concepts 10K Form

Sell
30

TMCI
Treace Medical Concepts

Last Price:
5.75
Seasonality Move:
7.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TMCI News And Ratings

See the #1 stock for the next 7 days that we like better than TMCI

TMCI Financial Statistics

Sales & Book Value

Annual Sales: $187.12M
Cash Flow: $-15.63M
Price / Cash Flow: 0
Annual Sales: $1.80
Price / Book: 3.19

Profitability

EPS (TTM): -1.02220
Net Income (TTM): $-63.68M
Gross Margin: $151.94M
Return on Equity: -47.93%
Return on Assets: -26.3%

Treace Medical Concepts Earnings Forecast

Key Treace Medical Concepts Financial Ratios

  • The Gross Profit Margin over the past 5 years for TMCI is 81.20%.
  • The Selling, General & Administrative Expenses for TMCI have been equal to 100.43% of Gross Profit Margin.
  • The Research & Development expenses have been 8.25% of Revenue.
  • The Interest Expense is -10.43% of Operating Income.
  • The Net Earning history of TMCI is -26.47% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Treace Medical Concepts Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TMCI
Website: treace.com

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 3.86
Quick Ratio: 2.71

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TMCI Technical Analysis vs Fundamental Analysis

Sell
30
Treace Medical Concepts (TMCI) is a Sell

Is Treace Medical Concepts a Buy or a Sell?